2024 annual financial data
Kiora Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was 53.49%.
Operating income was 4,510,288 USD and net income was 3,594,733 USD.
Operating cash flow was 8,559,115 USD.
Get free Kiora Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,000,000 USD
- Operating income
- 4,510,288 USD
- Net income
- 3,594,733 USD
- Operating cash flow
- 8,559,115 USD